Histone deacetylase inhibitors suppress rheumatoid arthritis fi broblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay
暂无分享,去创建一个
[1] L. Joosten,et al. Inhibition of HDAC Activity by ITF2357 Ameliorates Joint Inflammation and Prevents Cartilage and Bone Destruction in Experimental Arthritis , 2011, Molecular medicine.
[2] N. Damjanov,et al. HDAC Inhibition in Rheumatoid Arthritis and Juvenile Idiopathic Arthritis , 2011, Molecular medicine.
[3] P. François,et al. Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. , 2011, Blood.
[4] E. Verdin,et al. Regulatory signal transduction pathways for class IIa histone deacetylases. , 2010, Current opinion in pharmacology.
[5] R. Gay,et al. Epigenetics and rheumatoid arthritis: the role of SENP1 in the regulation of MMP-1 expression. , 2010, Journal of autoimmunity.
[6] S. Krausz,et al. Histone Deacetylase Inhibitors Suppress Inflammatory Activation of Rheumatoid Arthritis Patient Synovial Macrophages and Tissue , 2010, The Journal of Immunology.
[7] X Chen,et al. HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability , 2010, Oncogene.
[8] G. Firestein,et al. Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis , 2010, Immunological reviews.
[9] Yuan Shen,et al. Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis. , 2009, Experimental and molecular pathology.
[10] Patrick G. Shaw,et al. Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells , 2009, Breast Cancer Research and Treatment.
[11] N. Nishimoto,et al. Clinical value of blocking IL-6 receptor , 2009, Current opinion in rheumatology.
[12] Haruki Nakamura,et al. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay , 2009, Nature.
[13] P. Tak,et al. Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on? , 2008, Arthritis research & therapy.
[14] J. Keen,et al. Trichostatin A and 5 Aza-2′ deoxycytidine decrease estrogen receptor mRNA stability in ER positive MCF7 cells through modulation of HuR , 2008, Breast Cancer Research and Treatment.
[15] C. Lowenstein,et al. Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling , 2008, The Journal of experimental medicine.
[16] Oliver Distler,et al. Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts , 2007, Arthritis Research & Therapy.
[17] H. Moch,et al. Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. , 2007, Arthritis and rheumatism.
[18] R. Baron,et al. Anti‐rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen‐induced arthritis in rodents , 2007, British journal of pharmacology.
[19] Jeffrey Wilusz,et al. The highways and byways of mRNA decay , 2007, Nature Reviews Molecular Cell Biology.
[20] G. Fantuzzi,et al. Histone Hyperacetylation Is Associated with Amelioration of Experimental Colitis in Mice1 , 2006, The Journal of Immunology.
[21] C. Benz,et al. Rapid alteration of microRNA levels by histone deacetylase inhibition. , 2006, Cancer research.
[22] E. Seto,et al. Acetylation and deacetylation of non-histone proteins. , 2005, Gene.
[23] R. Gay,et al. Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis , 2005, Annals of the rheumatic diseases.
[24] K. Subbaramaiah,et al. Histone Deacetylase Inhibitors Suppress the Induction of c-Jun and Its Target Genes Including COX-2* , 2005, Journal of Biological Chemistry.
[25] P. Maslak. Erythrocyte Sedimentation Rate. , 2005, British medical journal.
[26] Masahiro Yamamura,et al. Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression. , 2004, Arthritis and rheumatism.
[27] P. Tak,et al. Activation of the STAT1 pathway in rheumatoid arthritis , 2004, Annals of the rheumatic diseases.
[28] Ae-June Wang,et al. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[29] A. V. van Kuilenburg,et al. Histone deacetylases (HDACs): characterization of the classical HDAC family. , 2003, The Biochemical journal.
[30] W. Greene,et al. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB , 2002, The EMBO journal.
[31] G. Fantuzzi,et al. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[32] A. Wolffe,et al. Chromatin remodeling and transcriptional activation: the cast (in order of appearance) , 2001, Oncogene.
[33] E. Vellenga,et al. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes. , 1999, Journal of immunology.
[34] F. Breedveld,et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. , 1997, Arthritis and rheumatism.
[35] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[36] P. Tak,et al. Function of histone deacetylase inhibitors in inflammation. , 2011, Critical reviews in immunology.
[37] 那須 義久. Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model , 2008 .
[38] Claudia Mauri,et al. Cells of the synovium in rheumatoid arthritis , 2007 .
[39] 佐藤栄一. DAS(disease activity score) , 2005 .
[40] W. Greene,et al. Shaping the nuclear action of NF-kappaB. , 2004, Nature reviews. Molecular cell biology.
[41] C. Sardet,et al. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. , 2003, The Journal of biological chemistry.
[42] W. Greene,et al. Duration of nuclear NF-kappaB action regulated by reversible acetylation. , 2001, Science.
[43] C. Werning. [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.